SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-21-000008
Filing Date
2021-05-07
Accepted
2021-05-06 20:07:17
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20210331.htm   iXBRL 10-Q 1248853
2 EX-31.1 nktr2021-03x31xexx311.htm EX-31.1 9519
3 EX-31.2 nktr2021-03x31xexx312.htm EX-31.2 9533
4 EX-32.1 nktr2021-03x31xexx321.htm EX-32.1 6036
  Complete submission text file 0000906709-21-000008.txt   5253276

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20210331.xsd EX-101.SCH 46282
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20210331_cal.xml EX-101.CAL 72093
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20210331_def.xml EX-101.DEF 180203
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20210331_lab.xml EX-101.LAB 473246
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20210331_pre.xml EX-101.PRE 290576
10 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20210331_htm.xml XML 749767
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 21899789
SIC: 2834 Pharmaceutical Preparations